Background: Reduction of 30-day all-cause readmissions for heart failure (HF) has become an important qualityof-care metric for health care systems. Many hospitals have implemented quality improvement programs designed to reduce 30-day all-cause readmissions for HF. Electronic medical record (EMR)-based measures have been employed to aid in these efforts, but their use has been largely adjunctive to, rather than integrated with, the overall effort. Objectives: We hypothesized that a comprehensive EMR-based approach utilizing an HF dashboard in addition to an established HF readmission reduction program would further reduce 30-day all-cause index hospital readmission rates for HF. Methods: After establishing a quality improvement program to reduce 30-day HF readmission rates, we instituted EMR-based measures designed to improve cohort identification, intervention tracking, and readmission analysis, the latter 2 supported by an electronic HF dashboard. Our primary outcome measure was the 30-day index hospital readmission rate for HF, with secondary measures including the accuracy of identification of patients with HF and the percentage of patients receiving interventions designed to reduce all-cause readmissions for HF. Results: The HF dashboard facilitated improved penetration of our interventions and reduced readmission rates by allowing the clinical team to easily identify cohorts with high readmission rates and/or low intervention rates. We significantly reduced 30-day index hospital all-cause HF readmission rates from 18.2% at baseline to 14% after implementation of our quality improvement program (P ¼ .045). Implementation of our EMR-based approach further significantly reduced 30-day index hospital readmission rates for HF to 10.1% (P for trend ¼ .0001). Daily time to screen patients decreased from 1 hour to 15 minutes, accuracy of cohort identification improved from 83% to 94.6% (P ¼ .0001), and the percentage of patients receiving our interventions, such as patient education, also improved significantly from 22% to 100% over time (P < .0001).
INTRODUCTION
Efforts to improve health care outcomes have expanded beyond reducing morbidity and mortality to include measures of cost and quality of life, such as reducing the incidence of early hospital readmissions. Coleman and others have focused on reducing readmissions by improving the transition of patient care from the inpatient to the outpatient setting.
1,2 The Centers for Medicare and Medicaid Services (CMS) has reinforced these efforts by incentivizing health care systems to reduce all-cause readmissions for patients discharged with certain diagnoses. 3 Heart failure (HF), the leading cause of hospitalization in the United States among adults older than 65 years, is one of the conditions for which readmissions are common, and many of these are thought to be preventable. CMS has thus instituted a financial penalty for hospitals with higher-than-expected 30-day all-cause readmission rates for patients discharged with a diagnosis of HF, acute myocardial infarction, pneumonia, chronic obstructive pulmonary disease, or total hip or total knee arthroplasty. 4 Many health care institutions have begun quality improvement projects in an effort to reduce all-cause HF readmissions. Evidencebased interventions targeted at reducing all-cause readmissions include early post-discharge telephone follow-up, 5 early postdischarge hospital visits, 6 medication reconciliation, 7, 8 and the use of risk stratification tools to identify and flag patients at high risk for readmission. 9 Prior to the CMS incentive to reduce all-cause readmissions, at Stanford Health Care (SHC) we instituted a program to reduce all-cause readmissions after discharge with a diagnosis of HF. Though we were able to reduce readmission rates initially, we noted gaps in our efforts that threatened sustainability: incomplete identification of patients diagnosed with HF prior to discharge, inability to accurately determine which HF patients were receiving interventions, and inability to track our data on a daily basis. We thus sought a more comprehensive, organized approach to reducing all-cause readmissions. We hypothesized that by reinforcing our initial efforts with informatics-based processes to help identify patients prior to discharge, track our interventions, and track our readmission data, we could further reduce 30-day all-cause index hospital readmission rates for patients discharged with HF diagnoses, and that this reduction could be sustained.
METHODS
In late 2011 we began a clinical project to reduce 30-day all-cause readmissions for HF at SHC, a tertiary care hospital with 490 beds and roughly 450 HF admissions per year. Our HF population demographics, which are similar to other recently studied cohorts, 10, 11 are as follows: 54% insured by Medicare, average age 71 years, and 55% male. The project involved a multidisciplinary team including physicians, nurses, and pharmacists meeting weekly to develop and implement interventions aimed at reducing all-cause readmission for HF. Tracking of patients readmitted to SHC occurred manually, and tabulation and analysis of readmitted patients lagged more than 1 month behind their readmission. Cohort identification was performed by clinical nurse specialists, who prospectively screened patients for HF diagnosis in hospital by using the electronic medical record (EMR) and tracked them using a spreadsheet (Microsoft Excel). This effort was fully implemented by January 1, 2012.
We received funding from the Gordon and Betty Moore Foundation to support a clinical nurse specialist and an informatics team dedicated to our project. We chose 4 main interventions: medication reconciliation, enhanced patient education using "teachback," early post-discharge telephone follow-up, and early postdischarge clinic follow-up.
Medication reconciliation was performed by inpatient pharmacists to ensure that patients were discharged with the appropriate medications and that adverse drug-drug interactions were avoided. Clinical HF nurses provided inpatient education, including but not limited to sodium restriction and disease management, using a teach-back process by which the patient repeats the information taught back to the educator. The post-discharge telephone call is a structured interview performed by a clinical HF nurse and solicits information regarding a patient's clinical status, ability to obtain and understand his or her medications, and outpatient clinic follow-up in an attempt to prevent hospital readmission. Finally, postdischarge clinic appointments provided clinical assessments focusing on management of volume status and reinforced patient education in the vulnerable post-discharge period to prevent readmissions.
Those patients deemed to be at high risk received earlier phone calls (within 48 h post discharge, as compared to 72 h) and were scheduled for post-discharge follow up (within 7 days post discharge, as compared to 14 days). Patients' risk for readmission was assessed by our clinical team using a combination of 2 previously validated readmission risk scores: the BOOST tool and the Yale Center for Outcome Research and Evaluation 30-day HF Readmission Score. 12, 13 After validating these scores in our own patient population, we characterized patients at high risk for readmission if they exhibited 2 of the following risk factors: polypharmacy, poor health literacy, no primary care provider, prior hospitalization (nonelective) in the past month, lack of caregiver/support person, or a Center for Outcome Research and Evaluation score >20%. Intervention tracking occurred manually, and was time consuming and often incomplete. To improve the accuracy and efficiency of our interventions, in late 2012 we instituted informatics-based solutions for each component of our process: cohort identification, intervention tracking, and readmission analysis, the latter 2 supported by the Stanford HF dashboard. These solutions were fully implemented by February 1, 2013.
COHORT IDENTIFICATION
At the beginning of our effort, there was a significant gap in our identification of patients with a primary discharge diagnosis of HF. Those patients coded as HF by our coding team but not identified by our clinician team would not receive our interventions, and a significant proportion were readmitted at 30 days. Patients are definitively identified as having a principal diagnosis of HF on discharge by our coding team only after discharge (while the clinical team needs to identify patients prior to discharge in order to intervene), and this process can take up to 7 days. The coding team reviews the patient chart to determine the principal International Statistical Classification of Diseases, 9
th Revision (ICD-9) discharge diagnosis, querying the discharging physician if there is uncertainty.
We have previously described our EMR-based approach to improving cohort identification.
14 Briefly, we constructed an automated EMR-based tool to allow our team to identify patients with HF more quickly and accurately. We selected criteria that could potentially identify the cohort as patients with an exacerbation of HF, in practice using a filter combining elevated brain natriuretic peptide level and ejection fraction measurement to screen inpatients and generate an electronic patient list, separate from the HF dashboard. The nursing team used this tool to screen patients admitted within 48 hours of the report being run for the presence of a primary diagnosis of HF. This allowed our nursing staff to screen patients with potential HF diagnoses and identify them more quickly, ensuring that they would receive our interventions prior to discharge.
INTERVENTION TRACKING AND READMISSION ANALYSIS: THE STANFORD HF DASHBOARD
The planning phase to determine our approach to improving intervention tracking and readmission analysis required weekly meetings among clinicians and the Stanford informatics team. This team determined the feasibility of an EMR-based approach and how best to automatically upload relevant information to a nearly real-time graphic user interface: the Stanford HF dashboard, which was constructed to enhance efficiency by incorporating clinician input. To streamline information collection and analysis, we created an HF readmission subject mart (Figure 1 ), a data repository that draws relevant information from various electronic sources, including the EMR (Epic Systems, Verona, WI, USA) and Press-Ganey patient satisfaction data. These datasets had previously been discrete, making collation of data inefficient. This data mart then uploaded relevant material to a graphical user interface, the Stanford HF dashboard, facilitating data tracking and analysis.
The Stanford HF dashboard (Figure 2 , video) automatically displays any patient coded with an ICD-9 primary diagnosis of HF upon discharge by the inpatient coding team. The ICD-9 diagnoses are chosen by the clinician team; we chose the diagnoses designated by CMS as part of the HF readmission penalty. There is typically a <24-hour delay before a patient's information displays on the dashboard after coding is complete. This quick turnaround allows time for clinician review of patients identified as having a primary diagnosis of HF by our coding team, but not thought to have HF by the clinician team (false positives), and permits timely correction of coding errors.
The "current state" dashboard displays 30-and 90-day readmission rates for HF based on the current date (eg, if the date were October 1, 2014, the dashboard would calculate the 30-day HF readmission rate from July 31, 2014, to August 30, 2014, as patients admitted after August 30 had not accrued 30 days out of hospital). We also tracked balance measures including emergency department visits and observational stays. One limitation of the dashboard is Heart Failure Dashboard Fig. 1 . Heart failure data mart. The heart failure data mart collects electronic data from available sources and places them in a single repository. This dataset serves as the "single source of truth" from which the heart failure dashboard is constructed. The finance source mart includes information from hospital accounts, ICD codes, inpatient admissions, emergency room admissions, and observation admissions; the encounter source mart houses information regarding medication reconciliation review, follow-up telephone calls, post-discharge appointments, and patient education; the Press-Ganey source mart includes patient satisfaction information. Fig. 2 . Stanford heart failure dashboard. The heart failure dashboard allows users to quickly view data pertinent to patients discharged with heart failure diagnoses. Users can view trends in readmissions over time and the proportion of patients receiving each intervention, and identify individual patients. This allows the clinical team to track recently discharged patients who need post-discharge interventions such as a follow-up telephone call or an appointment, increasing the likelihood that these interventions will be performed. One can also stratify the data by subgroup, including discharge unit, age, discharge floor, discharge status (eg, home or skilled nursing facility), payer type, and discharging physician. This allows the clinical team to easily identify cohorts with high readmission rates and/or low intervention rates, and introduce measures to improve those outcomes.
that it does not track all-cause readmissions to other hospitals. We have found on review that roughly 30%-40% of 30-day all-cause readmissions after HF discharge are to hospitals other than Stanford.
We built the dashboard to be interactive in order to allow caregivers to quickly drill down into specific subgroups to identify any trends in the readmission data. Readmission rates can thus be calculated for specific time periods and for different patient cohorts, per clinician interest. The interactive filters that enable stratification for our dashboard currently include but are not limited to age, discharge floor, payer type, discharge status (eg, home or skilled nursing facility), and discharging physician. For example, a clinician could look at the readmission rate of patients >80 years of age and generate a list of those patients. The ability to obtain an easily extractable list of readmitted patients allowed our team to focus on high-risk patients, such as those who are frequently readmitted.
The dashboard also displays the percentage of patients who have received our interventions. Medication reconciliation is tabulated in the EMR via electronic entry and uploaded to the dashboard. Teach-back by the nursing or pharmacy team is also captured via the EMR in a specially created data field. For the post-discharge phone call, a standardized EMR-based phone interview script with discrete fields was created. This allowed us to easily track not only completion of the phone calls, but the percentage of calls completed within the prespecified time period, and also to mine discrete data incorporated in the phone call to identify possible predictors of readmission, such as failure to obtain discharge medications or inability to perform daily weights at home. Post-discharge clinic follow-up is captured in the discharge template in the EMR via a dedicated data entry field (this metric captures whether the appointment was made in the prespecified time frame, but not whether the patient attended the appointment). Appointments within the Stanford system are automatically entered in the database, while appointment information for community providers is entered in a discharge flow sheet that uploads into the data mart.
The Stanford HF dashboard also allows our team to compare the list of patients coded with HF by our coding team against the list of patients identified with HF by our clinical team. This allows us to identify gaps in identification and improve the accuracy of our cohort identification.
Patients were identified as having HF on discharge with an ICD-9 diagnosis of 402. 9 . We included any patient 18 years of age or older in our cohort, regardless of insurance status (ie, we did not restrict our cohort to Medicare patients). Our criteria for a 30-day readmission were otherwise similar to the formula used to calculate the CMS penalty: any inpatient readmission to Stanford Hospital after being discharged with a primary diagnosis of HF counted as a readmission, unless the admission was observation status or elective, or the patient left against medical advice on the index discharge.
Statistical analysis for pairwise comparisons was performed using the Student t-test. Trend analysis was performed via a Cochran-Armitage trend test. We compared the 30-day readmission rates to SHC for patients discharged with a diagnosis of HF over 3 periods: baseline (preintervention, January 1, 2010, to December 31, 2011), the period after full implementation of our HF readmission task force (January 1, 2012, to January 31, 2013), and 12 months after full implementation of our EMR-based efforts (February 1, 2013 , to January 31, 2014).
RESULTS
The Stanford HF dashboard and our cohort identification tool led to improvements in cohort identification, the percentage of patients receiving interventions, and analysis of readmission data.
Cohort identification
As previously described, the operational work list for HF nurses created in the EMR made identification of these patients more efficient, reducing time spent screening patients from an average of 1 hour to 15 minutes. We reduced a baseline 17% discrepancy of patients coded as HF but not identified by our clinician team to 9.5% in the year after implementation of our cohort identification tool (P ¼ .006 for difference between baseline and year 1), and 5.4% in the ensuing year (P ¼ .03 for difference between years 1 and 2). Feedback to our coding team led to reclassification of some of these patients as having an HF diagnosis, further improving the accuracy of our cohort.
Intervention tracking
The ability to track our interventions allows us to determine systematic gaps in the uptake of those interventions, including particular units in our hospital that had not effectively implemented the interventions. Penetration of all interventions improved over time after implementation of our EMR-based approach. Use of teach-back as a standard for HF patient and caregiver education increased from 22% to 100% (P < .0001) from April 2013 to February 2014, while reconciliation of prior-to-admission medications by pharmacists improved from 55% to 100% (P < .0001).
Readmission rates
Our baseline 30-day all-cause index hospital readmission rate to Stanford Hospital after HF admission was 18.2% (January 1, 2010, to December 31, 2011; 170 patients readmitted out of 936 patients). Prior to implementation of our EMR-based approach, our 30-day readmission rates had decreased significantly to 14% (January 1, 2012, to January 31, 2013; 67 readmits out of 480 patients, P ¼ .045). Over the 12 months following implementation of the EMR-based approach, our 30-day all-cause index hospital readmission rate declined further to 10.1% (February 1, 2013 , to January 31, 2014; 40 readmits out of 397 patients) (Figure 3) . The trend for a decrease in index hospital readmission rates over these 3 time periods was significant (P ¼ .0001). This result was sustained 2 years after the EMR-based implementation (February 1, 2013, to January 31, 2015; 91 readmissions out of 817 patients, readmission rate 11.1%).
Based on data we received from CMS, all-cause readmissions for HF to hospitals other than Stanford comprised roughly 30-40% of total readmissions. To ensure that the reduction in index hospital readmission rates we noted at Stanford was similar to other hospitals, we reviewed data from the CMS Health Services Advisory Group from 2010 to 2014. This dataset allows us to capture allcause readmissions for patients with a primary diagnosis of HF discharged from Stanford to any hospital.
Our analysis of the data showed that our 30-day all-cause HF readmission rates for Medicare patients had decreased over time even when non-Stanford readmissions were included (from 26.2% in 2010 to 18.8% in 2014), and that the rate of decrease in all-cause readmissions outpaced both state and national cohorts over the same time period (Figure 4) . The most recent data from the publicly available Medicare Hospital Compare database corroborates this analysis, revealing that from July 7, 2012, to June 30, 2015, the 30-day readmission rate after HF discharges at our institution was 18.7%, significantly lower than the national rate of 21.9%. 15 
DISCUSSION
Given heightened concern over the high rate of readmission after discharge for HF in the United States, various interventions have been studied to reduce readmission rates. Early post-discharge clinic follow-up has been shown to be effective, 6 as have outpatient telephone interventions. 16, 17 Telemonitoring has also been employed, with mixed results, 5, 18 while invasive pulmonary artery pressure monitoring on an outpatient basis has shown some promise. 19 To our knowledge, this study is the first to demonstrate that an informatics-based approach to reducing all-cause readmissions for HF can reduce readmissions further in a setting where many of the above interventions are already employed. The HF dashboard added value by making virtually real-time process and outcome metrics available to front-line clinicians. This supports program sustainability by highlighting the value of the workflows impacting intervention delivery and thus improved patient outcomes. EMR-based enhancements have improved outcomes in a number of different settings. Heidenreich et al. 20, 21 found that EMR-based reminders could increase the use of evidence-based therapy for patients with HF, including beta blockers and implantable cardioverter defibrillators. Others have found that EMR-based reminders improve testing rates for human immunodeficiency virus and vaccination rates in elderly patients, 22 ,23 but these effects may not be sustained over time, due in part to "alert fatigue." Reminder-based EMR enhancements may thus serve as useful adjuncts to clinical care, but their ability to sustain improvements is unclear.
Our approach was to integrate the EMR into the daily workflow of our clinical project to improve efficiency, accuracy, and sustainability. This required early and frequent planning sessions between our clinical group and our clinical business analytics group to identify gaps in the initial state of our project and to determine how we could best address those gaps via an EMR-based approach. The team designing the dashboard received feedback from end users of the data, such as nurses and pharmacists, rather than fashioning the graphic user interface based on nonclinician input. This enhanced the usability and applicability of the interface to our clinical problem.
The dashboard proved instrumental in allowing us to easily and quickly track our outcomes, including surrogate measures such as the percentage of patients receiving interventions. A less easily measured but valuable benefit of the dashboard and our EMR-based approach was that it allowed us to perform rapid quality improvement projects within our overall HF readmission enterprise. The easily queried list of patients discharged with HF diagnoses allowed us to quickly perform serial root-cause analysis for readmitted patients and construct lists of patients with frequent readmissions. This analysis helped us identify patterns of readmissions we could potentially prevent, such as not providing HF medications on discharge or having inadequate social support.
Limitations of our study include its nonrandomized nature, making it difficult to determine whether the improvement in HF readmission rates we observed was due to the preexisting set of interventions or other changes happening over time rather than the EMR-based modifications. For example, it was recently shown that the national readmission rates for Medicare beneficiaries for "targeted conditions," including but not limited to HF, declined from 21.5% in 2007 to 17.8% in 2015. 24 This contrasts with data from less than a decade ago; the unadjusted 30-day all-cause readmission rates after discharge for HF diagnosis between 2004 and 2006 remained stable at roughly 23%. 25 It is difficult to perfectly separate the improvement in HF readmission rates noted in our institution from the improvement in national HF readmission rates, but we feel that the Health Services Advisory Group and CMS data we cite above does show that our hospital's improvement outpaced that of both national and state cohorts. Fig. 3 . Thirty-day readmission rates for heart failure patients at Stanford Hospital. This figure illustrates all-cause 30-day readmission rates for patients discharged with a primary diagnosis of heart failure (HF) over different time periods: our baseline cohort, prior to the quality effort to reduce HF readmissions, the period during which the quality improvement program to reduce readmissions was implemented, and the year after the electronic medical record enhancement was implemented. There were significant reductions in readmission rates over successive time periods.
